Diary of conferences and courses
Literature Information
Publication Date
2002-07-31
DOI
10.1039/B206608B
Impact Factor
4.616
Authors
View Original
Abstract
The first page of this article is displayed as the abstract.
Related Literature
Electric field-responsive photoluminescence color switching and reversible properties via Tb/Eu co-doped ergodic relaxor ferroelectrics
Hailing Sun, Yi Lok Chan, K. W. Kwok
2019-03-14
Paper
DOI: 10.1039/C9CP00324J
Ionic structure and transport properties of KF–NaF–AlF3 fused salt: a molecular dynamics study
Xiaojun Lv, Zexun Han, Hengxing Zhang, Qingsheng Liu, Jiangan Chen, Liangxing Jiang
2019-03-06
Paper
DOI: 10.1039/C9CP00377K
A comparative study of nitrobenzene reduction using model catalysts
Shuchang Wu, Yangming Lin, Bingwei Zhong, Guodong Wen, Hongyang Liu, Dang Sheng Su
2018-12-07
Communication
DOI: 10.1039/C8CP06175K
Shape adaptation of quinine in cyclodextrin cavities: NMR studies
Jacek Wójcik, Andrzej Ejchart, Michał Nowakowski
2019-03-01
Paper
DOI: 10.1039/C9CP00590K
DFT study of furfural conversion on a Re/Pt bimetallic surface: synergetic effect on the promotion of hydrodeoxygenation
He Dong, P. Hu
2019-03-22
Paper
DOI: 10.1039/C8CP07806H
First-principles studies of a two-dimensional electron gas at the interface of polar/polar LaAlO3/KNbO3 superlattices
Qiang Zhu
2019-03-18
Paper
DOI: 10.1039/C8CP07202G
The electric field modulation of electronic properties in a type-II phosphorene/PbI2 van der Waals heterojunction
Fei Wang, Wenli Zhang, Xiuwen Zhang
2019-03-14
Paper
DOI: 10.1039/C9CP00733D
A unified mechanism for ice and water electrical conductivity from direct current to terahertz
2019-03-22
Paper
DOI: 10.1039/C9CP00257J
CO2 condensation onto alkanes: unconventional cases of heterogeneous nucleation
Yensil Park
2019-03-28
Paper
DOI: 10.1039/C9CP00967A
Structural manifestation of partial proton ordering and defect mobility in ice Ih
2019-03-28
Paper
DOI: 10.1039/C9CP01234F
You might also like
Compound Q&A
Are there alternatives to 1-(4-Chlorophenyl)-N-hydroxymethanimine (CAS: 3848-36-0) in synthesis?
When considering alternatives to 1-(4-Chlorophenyl)-N-hydroxymethanimine (CAS: 3...
3848-36-01-(4-Chlorophenyl)-N...
Compound Q&A
How should (1R,9S,10S,12S,14E,16S,19R,20R,21S,22R)-3,9,21-Trihydroxy-5,10,12,14,16,20,22-heptamethyl-23,24-dioxatetracyclo[17.3.1.1~6,9~.0~2,7~]tetracosa-2,5,7,14-tetraen-4-one (CAS: 183202-73-5) be stored?
This compound should be stored in a cool, dry place away from direct sunlight. I...
183202-73-5(1R,9S,10S,12S,14E,1...
Compound Q&A
How is 3-(4-Bromophenyl)-5-(2-fluorophenyl)-1,2,4-oxadiazole (CAS: 419553-16-5) typically synthesized?
3-(4-Bromophenyl)-5-(2-fluorophenyl)-1,2,4-oxadiazole is synthesized through a m...
419553-16-53-(4-Bromophenyl)-5-...
Compound Q&A
How is 5-Chloro-2-(4-chlorophenyl)-4-methyl-6-[3-(1-piperidinyl)propoxy]pyrimidine (CAS: 1639220-19-1) typically synthesized?
5-Chloro-2-(4-chlorophenyl)-4-methyl-6-[3-(1-piperidinyl)propoxy]pyrimidine (CAS...
1639220-19-15-Chloro-2-(4-chloro...
Compound Q&A
What industries use 2-Chloro-4-(difluoromethoxy)pyridine (CAS: 1206978-15-5)?
2-Chloro-4-(difluoromethoxy)pyridine is used in the pharmaceutical industry for ...
1206978-15-52-Chloro-4-(difluoro...
Compound Q&A
What regulatory guidelines apply to 3-Chloro-6-methylpyridazine (CAS: 1121-79-5)?
3-Chloro-6-methylpyridazine (CAS: 1121-79-5) is classified under the Globally Ha...
1121-79-53-Chloro-6-methylpyr...
Compound Q&A
Are there alternatives to Methyl 4,5-dimethyl-2-nitrobenzoate in synthesis?
Several alternatives can be used in the synthesis of Methyl 4,5-dimethyl-2-nitro...
90922-74-0Methyl 4,5-dimethyl-...
Compound Q&A
Are there alternatives to (2E,2'E)-3,3'-(1,4-Phenylene)bisacrylaldehyde in synthesis?
Alternatives to (2E,2'E)-3,3'-(1,4-Phenylene)bisacrylaldehyde include other acry...
63405-68-5(2E,2'E)-3,3'-(1,4-P...
Compound Q&A
What is 3-Amino-5-chloropyridin-2-ol hydrochloride (CAS: 1261906-29-9)?
3-Amino-5-chloropyridin-2-ol hydrochloride is an organic compound with the CAS n...
1261906-29-93-Amino-5-chloropyri...
Compound Q&A
What precautions should be taken when handling 6,7-Difluoro-2,3-dihydro-4H-chromen-4-one (CAS: 1092349-93-3)?
When handling 6,7-Difluoro-2,3-dihydro-4H-chromen-4-one, it is essential to wear...
1092349-93-36,7-Difluoro-2,3-dih...
Source Journal
Analyst
CiteScore:
7.8
Self-citation Rate:
5.6%
Articles per Year:
653
Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.
Recommended Compounds
![2-{[(1R,2S)-2-Aminocyclohexyl]amino}-4-{[3-(2H-1,2,3-triazol-2-yl)phenyl]amino}-5-pyrimidinecarboxamide structure](https://static.chemtradehub.com/structs/137/1370261-96-3-40df.webp "2-{[(1R,2S)-2-Aminocyclohexyl]amino}-4-{[3-(2H-1,2,3-triazol-2-yl)phenyl]amino}-5-pyrimidinecarboxamide structure")
2-{[(1R,2S)-2-Aminocyclohexyl]amino}-4-{[3-(2H-1,2,3-triazol-2-yl)phenyl]amino}-5-pyrimidinecarboxamide
CAS Number:
1370261-96-3
Molecular Formula:
C19H23N9O
![6-Bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine structure](https://static.chemtradehub.com/structs/120/1203499-17-5-b4d1.webp "6-Bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine structure")
6-Bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine
CAS Number:
1203499-17-5
Molecular Formula:
C7H7BrN2O
N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinamine
CAS Number:
1032759-30-0
Molecular Formula:
C12H20BN3O2
Recommended Suppliers
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.